Skip to content
Louiza Labs logo

Louiza Labs

Louiza Labs is a YC Summer 2025 (S25) company. Based in San Francisco, CA, USA. Team of 3.

  • Marketing
  • Market Research

About Louiza Labs

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Louiza Labs builds an AI-powered intelligence platform that synthesizes real-world patient data for pharmaceutical teams managing post-market drugs. It surfaces the patient-level reasons drugs underperform commercially, specifically lack of effectiveness, poor adherence, and payer resistance, work previously done through manual market research and fragmented data vendors. The company's initial focus is women's health and GLP-1 therapeutics.

Go-to-market

Pharmaceutical commercial and medical affairs teams are the buyers, reached through a sales-led motion targeting post-launch drug portfolios in women's health and GLP-1 categories.

From the Y Combinator listing

How Louiza Labs describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

AI Powered Patient Insights + Pharmcuetical Intelligence

Synthesizing real-world patient insights into actionable data for post-market pharmaceuticals. We deliver real-world patient insights to pharmaceutical teams that explain the primary reasons drugs fail commercially: lack of effectiveness, poor adherence, and payer resistance. Focusing initially on women's health drugs + GLP-1's.

Facts

Industry
B2B / B2B -> Analytics
Location
San Francisco, CA, USA
Team size
3
Status
Active
Stage
Early

Founders (1)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works